Acadian Asset Management’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-84,972
Closed -$273K 1746
2024
Q4
$273K Sell
84,972
-296,432
-78% -$1.05M ﹤0.01% 1200
2024
Q3
$1.19M Buy
381,404
+62,868
+20% +$205K ﹤0.01% 879
2024
Q2
$998K Buy
318,536
+318,423
+281,790% +$1.17M ﹤0.01% 989
2024
Q1
$0 Sell
113
-11,697
-99% -$56.8K ﹤0.01% 1709
2023
Q4
$66K Buy
+11,810
New +$47.5K ﹤0.01% 1427

Other funds holding MURA

Acadian Asset Management's MURA Position: Q1 2025 in Review

Acadian Asset Management sold out of Mural Oncology (MURA) in Q1 2025, closing a stake of 84,972 shares — an estimated $273K sold.

Acadian Asset Management first reported a position in MURA in Q4 2023 and held it in 5 quarters. The position peaked at $1.19M in Q3 2024. 68 funds tracked by Wall St. Rank hold MURA as of Q1 2025.

  • Acadian Asset Management reported no remaining Mural Oncology position as of Q1 2025 after selling out during the quarter.
  • Acadian Asset Management sold 84,972 Mural Oncology shares in Q1 2025, an estimated $273K.
  • Acadian Asset Management first reported a position in Mural Oncology in Q4 2023 and held it in 5 quarters.
  • Acadian Asset Management's Mural Oncology position peaked at $1.19M in Q3 2024.
  • 68 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2025.

Based on Acadian Asset Management's 13F filing for Q1 2025, filed 21 May 2025.